# Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-transplant

> **NCT00171717** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 39 (actual)

## Conditions studied

- Maintenance Liver Transplant Patients With New Onset Diabetes

## Interventions

- **DRUG:** Cyclosporine - cyclosporine microemulsion

## Key facts

- **NCT ID:** NCT00171717
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2005-12
- **Final completion:** 2005-12
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2011-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00171717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00171717, "Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-transplant". Retrieved via MORVS 2026-11-02 from https://api.morvs.ai/clinical/NCT00171717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*